Search results
'Novo Nordisk is ripping off the American people,' Bernie Sanders says of Ozempic and Wegovy costs
NBC Universal via AOL· 2 hours agoSen. Bernie Sanders says the first question he is going to ask Novo Nordisk's CEO at a committee...
Bernie Sanders will grill Novo Nordisk's CEO over Ozempic and Wegovy prices
Quartz· 3 days agoCEO Lars Fruergaard Jørgensen will testify before the Senate's health committee after Sanders...
Sanders hopes pressure will force down Ozempic price
Axios· 3 hours agoSen. Bernie Sanders is trying to use the bully pulpit to lower the price of wildly popular anti-obesity drugs the same way he helped pushed drugmakers to...
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled...
Fortune via Yahoo Finance· 3 days agoThat’s what the American people want to see.” A vote in favor would have seen Langa face senators in...
Bernie Sanders to grill Novo Nordisk CEO on why weight-loss drugs Ozempic and Wegovy can cost up to...
INSIDER via Yahoo News· 4 days agoNovo Nordisk issued a response to Sanders in May, claiming it retained around 60% of the list price...
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
WSAU Wausau· 6 days ago(Reuters) - The U.S Senate Committee on Health, Education, Labor, and Pensions said on Friday that ...
Sanders drops subpoena effort after Novo Nordisk CEO agrees to testify
The Hill· 6 days ago-Vt.) on Friday dropped his pursuit of a subpoena for a top pharmaceutical executive after the...
Gateway - Quartz
Quartz· 3 days agoNovo Nordisk CEO Lars Fruergaard Jørgensen said Friday that the company’s experimental weight loss pill, Amycretin ...
Sanders drops Novo Nordisk subpoena threat
Becker’s Hospital Review· 3 days agoVermont Sen. Bernie Sanders has canceled a Senate committee vote that would have determined whether to subpoena Novo Nordisk executives about the cost of ...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 7 days agoThis was a race he couldn’t lose. Rival Novo Nordisk was already ahead. Its diabetes drug Ozempic...
